124 results
8-K
EX-99.2
VANI
Vivani Medical, Inc.
13 Aug 24
Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
4:29pm
or pills for long-term maintenance of GLP-1 therapy for weight management
Weight Loss Medicines Associated With Adherence Challenges Recent … ., 2017 GLP-1 implant every 6 months
Intarcia’s1 ITCA 650 (6-month exenatide implant) may be a relevant value analog for NPM-119 Value of long-term GLP-1
8-K
EX-99.1
VANI
Vivani Medical, Inc.
13 Aug 24
Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results
4:29pm
supporting the potential veterinary use of OKV-119, a miniature, long-term GLP-1 implant under development for the treatment of pre-diabetes, diabetes … compensation expense
Current operating lease liabilities
Total current liabilities
Long-term operating lease liabilities
Total liabilities
8-K
EX-99.1
VANI
Vivani Medical, Inc.
11 Jul 24
Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant Program, NPM-115
8:15am
Exhibit 99.1
FOR IMMEDIATE RELEASE
Vivani Medical Provides Update on Clinical Development Plans for Miniature, Long-term, GLP-1 Obesity Implant … ) (“Vivani” or the “Company”), an innovative, biopharmaceutical company developing novel, long-term drug implants, today announced that it expects
8-K
EX-99.1
VANI
Vivani Medical, Inc.
13 Jun 24
Other Events
8:01am
Exhibit 99.1
Vivani Medical Announces FDA Clears Investigational New Drug
Application and Lifts Clinical Hold for NPM-119, a Miniature Long-Term
Subdermal … with oral and injectable type 2 diabetes medications, by providing
long-term therapeutic delivery of exenatide for six months
Study will represent first
8-K
EX-99.1
lcfpl59 fxqki76p9bi
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
8-K
EX-99.2
pwu0o6pfdx kxiiu24
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
8-K
EX-99.1
kotjqkrggs
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-99.2
iob6wzs4yj7yn
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-99.1
5mu6s2qjy fzvqlbg
6 Mar 24
Vivani Medical Appoints Daniel Bradbury to its Board of Directors
8:30am
8-K
EX-99.1
py3x7azh
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
424B5
16p hbjdvj
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.1
l9hrvkc552 r8f
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.2
uu1v3cb
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
6kn58
14 Nov 23
Results of Operations and Financial Condition
6:06am